Gastrointestinal
Proton pump inhibitors (PPIs)
The most powerful suppressors of gastric acid: they block the final step of acid secretion and are the backbone of peptic ulcer and reflux treatment.
Mécanisme d’action
- Taken as enteric-coated prodrugs, they pass the stomach intact and are absorbed in the duodenum.
- In the parietal cell they are converted to the active drug, which binds covalently to the H+/K+-ATPase, the proton pump.
- The proton pump is the last step in acid secretion, so both basal and stimulated secretion fall by more than 90%.
- The block lasts until new pump enzyme is made (about 18 hours), long after the drug has left the blood.
Cibles moléculaires
- H+/K+-ATPase (proton pump) of parietal cells: Irreversible inhibitor (covalent)
Médicaments : Proton pump inhibitors (PPIs)
- Omeprazole
- Esomeprazole
- Lansoprazole
- Pantoprazole
- Rabeprazole
- Dexlansoprazole
Indications thérapeutiques
- Healing gastric and duodenal ulcers, and preventing or treating NSAID-induced ulcers
- Helicobacter pylori eradication, with two antibiotics
- Gastro-oesophageal reflux disease and erosive oesophagitis
- Zollinger-Ellison syndrome
- Stress ulcer prevention in critically ill patients
Maladies traitées
Pharmacocinétique
- Taken 30 to 60 minutes before breakfast or the largest meal of the day, for the greatest effect.
Effets indésirables
- Generally well tolerated
- Long-term use: fractures, low vitamin B12, poorer absorption of calcium carbonate
- Diarrhoea, including Clostridium difficile colitis
Contre-indications selon le terrain
- Osteoporosis (Avec précaution): Long-term acid suppression is associated with fractures.
- Taking clopidogrel (omeprazole, esomeprazole) (Avec précaution): They inhibit CYP2C19 and reduce the activation of clopidogrel.
Autres précautions et interactions
- Long-term use is linked with Clostridioides difficile infection and low magnesium and vitamin B12.
Sujets liés
Rédigé d’après
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 40, Gastrointestinal and Antiemetic Drugs, II.C Inhibitors of the H+/K+-ATPase proton pump
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.